Hematology/Oncology Grand Rounds

Hem/Onc Grand Rounds takes place every Thursday from 7:45-8:45 a.m. in T2500

January 2013

January 3
"Recent Advances & Future Directions in Hormonal Management of Metastatic Breast Cancer"
Harold Harvey, M.D.

December 2012

December 20
"Review of ASH and San Antonio 2012 - #2"
Witold Rybka, M.D.
W. Christopher Ehmann, M.D.
Cristina Truica, M.D.

December 13
"Review of ASH 2012 - #1"
David Claxton, M.D.
Mark Kirschbaum, M.D.
Elliot Epner, MD, Ph.D.

December 6
"ACT 13: Patient Safety - Report Requirements"
Debra Verne, R.N., M.P.A., C.P.H.R.M.
Carol Freer, M.D.

November 2012

November 29
"Complement and Thrombotic Microangiopathies"
John Chapin, M.D. - New York Presbyterian Hospital, Weill Cornell College of Medicine

November 15
"Combined Epigenetic and Immunotherapy for Hematologic Malignancies"
Elliot Epner, M.D., Ph.D.

November 8
"The Role of Diabetes and Other Factors Associated with Local and Distal Recurrence with Surgically-Resected Non-Small Cell Lung Cancer"
John Varlotto, M.D.

October 2012

October 18
"Therapeutic Targets in Non-Small Cell Lung Cancer"
Yuxia Jia, M.D., Ph.D. - Columbia University Medical Center

October 11
"Serum Periostin and Survival in Metastatic Breast Cancer"
Nicholas E. Lamparella, D.O., Cancer Institute, Chief Fellow, Hematology/Oncology
"Development of Proteomic Biomarkers for Early Lung Cancer Detection and Development"
Amit Barochia, M.D., Cancer Institute, Fellow III, Hematology/Oncology
"Targeting B-Raf and K-Ras Mutation to Reverse De-Novo Resistance to EGFR TKIs in Non-Small Cell Lung Cancer"
Monika Joshi, M.D., Cancer Institute, Fellow III, Hematology/Oncology

October 4
"Intermittent VEGF Targeted Therapy in Metastatic Renal Cell Carcinoma (mRCC)"
Sarmad Sadeghi, M.D., M.S., Ph.D.